Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming - Takeaways - MDSpire

Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming

  • By

  • Wentao Dong

  • Yang Li

  • Zhuolin Wu

  • Quanlin Fu

  • Jinshuang Zhao

  • Bangyue Wang

  • Jia Yao

  • Chenglu Lu

  • Minfeng Tong

  • June 10, 2026

  • 0 min

Share

  • 1

    Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, with a median survival of approximately 15 months despite current therapies.

  • 2

    The immunosuppressive tumor microenvironment in GBM disables cytotoxic lymphocyte function, rendering conventional immunotherapy largely ineffective.

  • 3

    Recent advances in single-cell RNA sequencing and spatial multiomics have revealed diverse cytotoxic lymphocyte subpopulations in GBM.

  • 4

    Distinct immune niches within GBM tumors influence the functional state of CD8+ T cells and NK cells, impacting their therapeutic accessibility.

  • 5

    The review proposes precision immunotherapy strategies tailored to the unique immunobiology of the CNS tumor microenvironment in GBM.

Original Source(s)

Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming

  • by Wentao Dong, Yang Li, Zhuolin Wu, Quanlin Fu, Jinshuang Zhao, Bangyue Wang, Jia Yao, Chenglu Lu, Minfeng Tong

  • June 10, 2026

Related Content

Efficacy and safety of hyperthermic intraperitoneal chemotherapy in treatment of primary or recurrent ovarian cancer: systematic review and meta-analysis

Primary large cell neuroendocrine carcinoma of the breast with metastasis in the lymph nodes: a case report and literature review

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study